mhurhangee/ep-ind-claims huggingface dataset:
A cigarette production method comprising: a send-out step of arranging and sending out a plurality of first and second filter tips (1, 2) each containing filter fibers and extending in an axial direction, whereby two first filter tips having mouth-side end faces facing each other are arranged between two second filter tips; a filter plug forming step of butting the plurality of filter tips (1, 2) in the axial direction, wrapping the butted filter tips (1, 2) in an outer plug wrapper to form a filter rod, and cutting the filter rod approximately at the longitudinal center of each of the second filter tips to form filter plugs each comprising filters for two cigarettes arranged to face each other; and an exposure step of placing cigarette rods at opposite ends of each filter plug and wrapping the filter plug and the cigarette rods in tipping paper to form a double cigarette and cutting the filter plug and thereby exposing end faces of the first filter tips, wherein a distinguishing-indicator forming step is carried out before the send-out step to form distinguishing-indicators (15a, 15b) on the mouth-side end faces of the first filter tips (1a, 1b) to be exposed in the exposure step, the distinguishing indicators being visually distinguishable from the filter fibers, and in the send-out step, the first filter tips (1a, 1b) whose distinguishing indicators (15a, 15b) differ from each other are placed such that the distinguishing indicators (15a, 15b) face each other. a send-out step of arranging and sending out a plurality of first and second filter tips (1, 2) each containing filter fibers and extending in an axial direction, whereby two first filter tips having mouth-side end faces facing each other are arranged between two second filter tips; a filter plug forming step of butting the plurality of filter tips (1, 2) in the axial direction, wrapping the butted filter tips (1, 2) in an outer plug wrapper to form a filter rod, and cutting the filter rod approximately at the longitudinal center of each of the second filter tips to form filter plugs each comprising filters for two cigarettes arranged to face each other; and an exposure step of placing cigarette rods at opposite ends of each filter plug and wrapping the filter plug and the cigarette rods in tipping paper to form a double cigarette and cutting the filter plug and thereby exposing end faces of the first filter tips, wherein a distinguishing-indicator forming step is carried out before the send-out step to form distinguishing-indicators (15a, 15b) on the mouth-side end faces of the first filter tips (1a, 1b) to be exposed in the exposure step, the distinguishing indicators being visually distinguishable from the filter fibers, and in the send-out step, the first filter tips (1a, 1b) whose distinguishing indicators (15a, 15b) differ from each other are placed such that the distinguishing indicators (15a, 15b) face each other.
A medical device, particularly for mixing medical fluids, comprising two distinct and coaxial tubular bodies (1, 2), of which a first body is made of a first plastic material and is formed with a hollow spike that can be inserted in a container for medical fluid, and a second body is made of a second plastic material more elastic than the first material and has an outlet set on the side opposite to said spike, wherein said two bodies (1, 2) have respective open ends (7, 11) to be joined together, of which the end of the second body is inserted axially by friction within the end of the first body and blocked via a substantially irreversible connection, said device being characterized in that said substantially irreversible connection consists of radial projections engaged against said end of the second body, obtained by plastic deformation of the wall of the end of the first body following upon insertion of said end of the second body within said end of the first body, in that said end of the second body is inserted axially between said end of the first body and a coaxial tubular appendage defining with said end of the first body an annular gap, and in that the dimensions of the outer and inner surfaces of the end of the second body are such as to provide a forced fit by friction, respectively, with the inner surface of the end of the first body and with the outer surface of the tubular appendage.
An electroluminescent device comprising a layer system with a substrate electrode on top of a substrate and at least one stack of subsequent layers comprising a counter electrode and an electroluminescent layer stack with at least one organic electroluminescent layer wherein the electroluminescent layer stack is arranged between the substrate electrode and the counter electrode, and at least one electrical shunt means (122, 122', 122") applied to the top of the substrate electrode to improve the current distribution over the substrate electrode, the electrical shunt means (122, 122', 122") is applied to the substrate electrode via at least one electrical connecting means, whereas the electrical connecting means and the shunt means (122, 122', 122") are arranged outside the stack of subsequent layers, wherein the electroluminescent device comprises an encapsulation means, which is arranged for encapsulating at least the electroluminescent layer stack, characterized in that an electrical contact means is arranged in between the encapsulation means and the counter electrode for electrically contacting the counter electrode to the encapsulation means, wherein the electrical contact means is performed as electrical conductive glue arranged in direct contact within the counter electrode as well as an inner surface of the encapsulation means.
A vitrification carrier for a biological sample, wherein said carrier includes a body and a sealing cap, and wherein the near end of the body and the bottom of the sealing cap are sealable to form a sealed placing area for a frozen sample, and a placing platform for a frozen sample is set in said placing area for a frozen sample, and a coolant circulation channel is set on said body, and at least one flow-through pore corresponding to said coolant circulation channel is set on said sealing cap so as to enable the coolant in the circulation channel to contact with the outside surface of the placing area for a frozen sample when the biological sample is subjected to cryopreservation, thereby cooling the biological sample; wherein said placing platform (a) is fixed on the top of the near end of the body; or (b) is fixed on the bottom of said sealing cap; and said body further includes a gripping part at the distal end of the body, and said channel has at least one distal opening located on the gripping part and at least one side opening located on the side wall of the body, and said at least one distal opening communicates with said at least one side opening, and said at least one flow-through pore corresponds to said at least one side opening when the sealing cap is sealed with the body. (a) is fixed on the top of the near end of the body; or (b) is fixed on the bottom of said sealing cap; and
A composition comprising: a cyclohexanedione oxime or an agriculturally acceptable salt thereof; and an effective amount of one or more stabilizing surfactants to provide a stabilized cyclohexanedione oxime, wherein the surfactant comprises a mixture of one or more anionic surfactants and one or more nonionic surfactants, wherein the anionic surfactant is selected from the group consisting of phosphoric mono- and di-esters of long-chain alcohols having 14 to 22 carbon atoms and the salts thereof, phosphoric mono-and di-esters of alkylene oxide addition products of long-chain alcohols having 14 to 22 carbon atoms and the salts thereof, alkylsulfates having 14 to 22 carbon atoms, polyoxyethylene alkyl ether sulfates of alcohols having 14 to 22 carbon atoms, alkane sulfonates having 14 to 22 carbon atoms, and olefin sulfonates having 14 to 22 carbon atoms, and wherein the nonionic surfactant is selected from the group consisting of castor oil ethoxylates, alcohol ethoxylates, tristyrylphenol ethoxylates, ethoxylated sorbitan fatty acid esters and mixtures thereof; wherein the composition is free of an epoxidized oil fatty acid or epoxidized ester of a fatty acid. a cyclohexanedione oxime or an agriculturally acceptable salt thereof; and an effective amount of one or more stabilizing surfactants to provide a stabilized cyclohexanedione oxime, wherein the surfactant comprises a mixture of one or more anionic surfactants and one or more nonionic surfactants, wherein the anionic surfactant is selected from the group consisting of phosphoric mono- and di-esters of long-chain alcohols having 14 to 22 carbon atoms and the salts thereof, phosphoric mono-and di-esters of alkylene oxide addition products of long-chain alcohols having 14 to 22 carbon atoms and the salts thereof, alkylsulfates having 14 to 22 carbon atoms, polyoxyethylene alkyl ether sulfates of alcohols having 14 to 22 carbon atoms, alkane sulfonates having 14 to 22 carbon atoms, and olefin sulfonates having 14 to 22 carbon atoms, and wherein the nonionic surfactant is selected from the group consisting of castor oil ethoxylates, alcohol ethoxylates, tristyrylphenol ethoxylates, ethoxylated sorbitan fatty acid esters and mixtures thereof; wherein the composition is free of an epoxidized oil fatty acid or epoxidized ester of a fatty acid.
A surgical fastening device, comprising: an elongate shaft; an end effector coupled to a distal end of the elongate shaft, the end effector including a cartridge jaw and an anvil pivotally coupled to one another and configured to engage tissue there between; a staple cartridge configured to be removably disposed within a channel formed in the cartridge jaw, the staple cartridge including a plurality of staples disposed therein; characterised by comprising: a latch formed on one of the cartridge jaw and the staple cartridge, the latch being configured to extend into a corresponding engagement feature formed in the other one of the cartridge jaw and the staple cartridge when the staple cartridge is fully seated within the cartridge jaw, wherein the latch protrudes radially outward beyond an outer diameter of the elongate shaft and end effector when the latch is not engaged with the corresponding engagement feature. an elongate shaft; an end effector coupled to a distal end of the elongate shaft, the end effector including a cartridge jaw and an anvil pivotally coupled to one another and configured to engage tissue there between; a staple cartridge configured to be removably disposed within a channel formed in the cartridge jaw, the staple cartridge including a plurality of staples disposed therein; characterised by comprising: a latch formed on one of the cartridge jaw and the staple cartridge, the latch being configured to extend into a corresponding engagement feature formed in the other one of the cartridge jaw and the staple cartridge when the staple cartridge is fully seated within the cartridge jaw, wherein the latch protrudes radially outward beyond an outer diameter of the elongate shaft and end effector when the latch is not engaged with the corresponding engagement feature.
Method for validating a homogenizing valve, comprising the steps of: - preparing an emulsion having a hydrophilic phase comprising, in weight percentage on the total weight: from 55% to 74% demineralized water, from 10% to 20% glycerin and from 3% to 4.2% butylene glycol, and a lipophilic phase comprising, in weight percentage on the total weight: from 5.1% to 5.9% squalane, from 7.2% to 8.8% caprylic acid alkyl ester and from 0.665% to 0.735% cetyl alcool; - subjecting said emulsion to forced passage within said homogenizing valve from a high pressure zone to a low pressure zone from 15 to 20 times. - preparing an emulsion having a hydrophilic phase comprising, in weight percentage on the total weight: from 55% to 74% demineralized water, from 10% to 20% glycerin and from 3% to 4.2% butylene glycol, and a lipophilic phase comprising, in weight percentage on the total weight: from 5.1% to 5.9% squalane, from 7.2% to 8.8% caprylic acid alkyl ester and from 0.665% to 0.735% cetyl alcool; - subjecting said emulsion to forced passage within said homogenizing valve from a high pressure zone to a low pressure zone from 15 to 20 times.
A harvesting head height control circuit for controlling the height of an articulated harvesting head that is supported on a combine harvester during harvesting in an agricultural field, the articulated harvesting head including a center section, a left section, and a right section, wherein the left section is coupled to the center section and extends leftward therefrom, wherein the right section is coupled to the center section and extends rightward therefrom, wherein a first actuator is coupled to the to the left section to raise the left section with respect to the center section, wherein a second actuator is coupled to the right section to raise the right section with respect to the center section, wherein the harvesting head height control circuit comprises an ECU coupled to the first actuator to raise and lower the left section, and coupled to the second actuator to raise and lower the right section; characterized in that the harvesting head height control circuit comprises: a first load sensor coupled to the ECU and disposed to sense a first force acting rearwardly against the left section and configured to generate a first signal indicative of the first force; and a second load sensor coupled to the ECU and disposed to sense a second force acting rearwardly against the right section and configured to generate a second signal indicative of the second force; and that the ECU is configured to receive the first signal and the second signal and to responsively raise and lower the left section and the right section based at least on a magnitude of the first signal and the second signal. a first load sensor coupled to the ECU and disposed to sense a first force acting rearwardly against the left section and configured to generate a first signal indicative of the first force; and a second load sensor coupled to the ECU and disposed to sense a second force acting rearwardly against the right section and configured to generate a second signal indicative of the second force; and that the ECU is configured to receive the first signal and the second signal and to responsively raise and lower the left section and the right section based at least on a magnitude of the first signal and the second signal.
An aldose reductase inhibitor for use in the treatment of a colon cancer, lung cancer or metastatic cancer derived wherefrom or symptoms thereof resulting from aldose reductase-mediated signaling in a cytotoxic pathway in a subject, wherein the aldose reductase inhibitor is a small interfering RNA (siRNA) with the sequence shown in SEQ ID NO: 1.
A method performed at a user equipment, UE, the method comprising: receiving an allocation of a first resource from a network, the first resource available to the UE for transmission of control information to the network; identifying a data transmission inactivity associated with the UE (1260, 1282); responsive to the identifying, implicitly releasing the first resource (1262, 1284); requesting a subsequent resource from the network; and reusing the first resource for communication of control information to the network. receiving an allocation of a first resource from a network, the first resource available to the UE for transmission of control information to the network; identifying a data transmission inactivity associated with the UE (1260, 1282); responsive to the identifying, implicitly releasing the first resource (1262, 1284); requesting a subsequent resource from the network; and reusing the first resource for communication of control information to the network.
A surface roughening agent for aluminum, comprising an aqueous solution containing an alkali source, wherein the alkali source is NaOH or KOH; an amphoteric metal ion, wherein the amphoteric metal ion is Zn ion, Pb ion, Sn ion, Sb ion or Cd ion; a nitrate ion, and a thio compound, wherein the thio compound is at least one selected from a thiosulfate ion, thiourea, ammonium thioglycolate, thioglycolic acid, thioglycerol, L-thioproline, dithiodiglycolic acid, β,β'-thiodipropionic acid, sodium N,N-diethyldithiocarbamate trihydrate, 3,3'-dithiodipropionic acid, 3,3'-dithiodipropanol, o-thiocresol and p-thiocresol; wherein a content of the thio compound is 0.05 to 25.0% by weight; wherein a hydroxide ion-equivalent content of the alkali source is 0.60 to 22.80% by weight; wherein a content of the amphoteric metal ion is 0.2 to 6.0% by weight; and wherein a content of the nitrate ion is 0.5 to 10.0% by weight.
A V-bank filter comprising: a first pair of pleated filter elements arranged in a vee configuration; a second pair of pleated filter elements arranged in a vee configuration; and a housing comprising: a first side panel and a second side panel, wherein each of the side panels (106, 108) includes a first edge and a second edge, wherein the first edge is upstream of the V-bank filter, and wherein the first and second pairs of pleated filter elements are disposed in the housing, the housing and filter element pairs (672, 678) comprising a unitary disposable filter, wherein a centerline defined by the first pair of pleated filter elements dividing the angle between the pleated filter elements of the first pair into two equal angles defines an acute angle at a location upstream of the V-bank filter with a centerline defined by the second pair of pleated filter elements dividing the angle between the pleated filter elements of the second pair into two equal angles, and wherein two filter elements comprising the first and second pairs (672, 678) form outer vee pairs. a first pair of pleated filter elements arranged in a vee configuration; a second pair of pleated filter elements arranged in a vee configuration; and a housing comprising: a first side panel and a second side panel, wherein each of the side panels (106, 108) includes a first edge and a second edge, wherein the first edge is upstream of the V-bank filter, and wherein the first and second pairs of pleated filter elements are disposed in the housing, the housing and filter element pairs (672, 678) comprising a unitary disposable filter, wherein a centerline defined by the first pair of pleated filter elements dividing the angle between the pleated filter elements of the first pair into two equal angles defines an acute angle at a location upstream of the V-bank filter with a centerline defined by the second pair of pleated filter elements dividing the angle between the pleated filter elements of the second pair into two equal angles, and wherein two filter elements comprising the first and second pairs (672, 678) form outer vee pairs. a first side panel and a second side panel, wherein each of the side panels (106, 108) includes a first edge and a second edge, wherein the first edge is upstream of the V-bank filter, and wherein the first and second pairs of pleated filter elements are disposed in the housing, the housing and filter element pairs (672, 678) comprising a unitary disposable filter, wherein a centerline defined by the first pair of pleated filter elements dividing the angle between the pleated filter elements of the first pair into two equal angles defines an acute angle at a location upstream of the V-bank filter with a centerline defined by the second pair of pleated filter elements dividing the angle between the pleated filter elements of the second pair into two equal angles, and wherein two filter elements comprising the first and second pairs (672, 678) form outer vee pairs.
Chromatography media comprising a plurality of staple fibers as individual discrete entities, said fibers being high surface area fibers, the fibers having a cross-section comprising a body region defining a substantially longitudinal axis, and a plurality of projections extending radially outwardly from said body region, characterized in that said fibers comprise surface pendant chromatographic groups consisting of ion-exchange groups, hydrophobic groups and/or affinity chromatography groups.
Cosmetic preparation in the form of an O/W emulsion, comprising a) from 0.1% by weight to 2.5% by weight of one or more alkane-1,2-diols with an alkyl chain having from 3 to 5 carbon atoms, b) two or more emulsifiers, containing at least one O/W emulsifier having an HLB value greater than 8 and at least one W/O emulsifier having an HLB value up to a maximum of 8, c) one or more fatty alcohols selected from aliphatic, linear, primary alkanols having a chain length of from 6 to 22 carbon atoms, d) one or more oils liquid at 20°C and 1013 hPa, e) one or more waxes which melt from a temperature of 40°C at 1013 hPa without decomposition, f) one or more saturated and/or unsaturated linear carboxylic acids having a chain length of from 10 to 20 carbon atoms, g) one or more active ingredients with antiperspirant action, and h) water, based in each case on the total weight of the preparation, the cosmetic preparation having a penetration force value of from 300 gram-force to 600 gram-force. a) from 0.1% by weight to 2.5% by weight of one or more alkane-1,2-diols with an alkyl chain having from 3 to 5 carbon atoms, b) two or more emulsifiers, containing at least one O/W emulsifier having an HLB value greater than 8 and at least one W/O emulsifier having an HLB value up to a maximum of 8, c) one or more fatty alcohols selected from aliphatic, linear, primary alkanols having a chain length of from 6 to 22 carbon atoms, d) one or more oils liquid at 20°C and 1013 hPa, e) one or more waxes which melt from a temperature of 40°C at 1013 hPa without decomposition, f) one or more saturated and/or unsaturated linear carboxylic acids having a chain length of from 10 to 20 carbon atoms, g) one or more active ingredients with antiperspirant action, and h) water,
A zinc/histidine/polyglutamic acid complex prepared from histidine, polygamma glutamic acid and a zinc supply, wherein the histidine is L-histidine, and wherein the complex is prepared from 30 to 70 parts by weight of the polygamma glutamic acid and 30 to 150 parts by weight of the zinc supply based on 200 parts by weight of the histidine.
A thermal patch, comprising: an array of heating pads; and a plurality of stretchable conductors interconnecting each of the array of heating pads with adjacent heating pads, the stretchable conductors being shaped as a lateral spring structure between a first heating pad and an adjacent second heating pad, wherein the stretchable conductors are configured to be increasable in lateral distance between the first and second heating pads by stretching of their spring structure. an array of heating pads; and a plurality of stretchable conductors interconnecting each of the array of heating pads with adjacent heating pads, the stretchable conductors being shaped as a lateral spring structure between a first heating pad and an adjacent second heating pad, wherein the stretchable conductors are configured to be increasable in lateral distance between the first and second heating pads by stretching of their spring structure.